GL1X · GenesisL1 explorer

Research workbench

BTGH84 mutant with covalent modification by MA3 in complex with pugnac

Analyse BTGH84 mutant with covalent modification by MA3 in complex with pugnac in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5MI5
Type
protein
Length
677 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
O-glcnacase BT_4395
EC
3.2.1.169, 3.2.1.52
UniProt
Q89ZI2
Ligands
OAN, 7NQ, CA
Pockets
9 · best druggability 0.61

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AO-glcnacase BT_4395 (EC 3.2.1.169, 3.2.1.52)protein67740% helix, 19% strandQ89ZI2

Ligands and binding sites

  • OAN · O-(2-acetamido-2-deoxy D-glucopyranosylidene) amino-N-phenylcarbamate · ligand · chains A
  • 7NQ · ~{N}-(4-ethoxyquinazolin-2-yl)propanamide · ligand · chains A
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13070.610.7841empty
21080.590.8521OAN
31460.500.7920empty
41590.420.7425empty
5700.370.7817empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 5MI5 · BtGH84 mutant with covalent modification by MA3 in complex with PUGNAc · the same entry in another collection · chain A against A, TM-score 1.00
  • Q89ZI2 · AlphaFold monomer V2.0 prediction for O-glcnacase BT_4395 (Q89ZI2) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.